Janney Capital analyst Chiara Russo raised her fair value target on Cara Therapeutics (NASDAQ: CARA) to $27.00 (from $25.00) announced ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Cara Therapeutics (CARA) PT Raised to $34 at Piper JaffrayJuly 24, 2015 11:30 AM Cara Therapeutics (CARA) PT Raised to $27 at Needham & CompanyJuly 23, 2015 9:50 AM Cara Therapeutics (CARA) Announces Statistically Significant Results From Phase 2 Trial in Uremic PruritusJuly 23, 2015 8:45 AM Cara Therapeutics Announces Positive Results From Phase 2 Trial in Uremic PruritusJuly 23, 2015 7:01 AM